Search results for "Neoplasm Recurrence"

showing 10 items of 422 documents

Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease

1992

SummaryThis paper is an up-dated review of the role of systemic chemotherapy in the management of recurrent and/or metastatic head and neck carcinoma.

0301 basic medicinemedicine.medical_specialtymedicine.medical_treatment030106 microbiologyAntineoplastic AgentsDiseaseHead neck cancer03 medical and health sciences0302 clinical medicinemedicineHumansPharmacology (medical)Head and neckHead and neck carcinomaPharmacologyChemotherapybusiness.industrySystemic chemotherapyHead and neck cancerAdvanced stagemedicine.diseaseSurgeryInfectious DiseasesOncologyHead and Neck Neoplasms030220 oncology & carcinogenesisRadiologyNeoplasm Recurrence Localbusiness
researchProduct

Exosome levels in human body fluids: A tumor marker by themselves?

2016

Despite considerable research efforts, the finding of reliable tumor biomarkers remains challenging and unresolved. In recent years a novel diagnostic biomedical tool with high potential has been identified in extracellular nanovesicles or exosomes. They are released by the majority of the cells and contain detailed molecular information on the cell of origin including tumor hallmarks. Exosomes can be isolated from easy accessible body fluids, and most importantly, they can provide several biomarkers, with different levels of specificity. Recent clinical evidence shows that the levels of exosomes released into body fluids may themselves represent a predictive/diagnostic of tumors, discrimin…

30030301 basic medicinePharmaceutical ScienceExosomesBioinformaticsExosome03 medical and health sciencesTumor BiomarkersProstate cancer0302 clinical medicineBody FluidNeoplasmsBiomarkers TumorHumansMedicineHigh potentialTumor markerBiomarkers; Body fluids; Early diagnosis; Exosomes; Extracellular vesicles; Follow-up; Prostate cancer; Biomarkers Tumor; Body Fluids; Humans; Neoplasm Recurrence Local; Neoplasms; Exosomes; 3003Prostate cancerSettore BIO/16 - Anatomia Umanabusiness.industryFollow-upHealthy subjectsCancerBiomarkerExtracellular vesiclesEarly diagnosiEarly diagnosismedicine.diseaseMicrovesiclesBody FluidsExosomeBody fluids030104 developmental biology030220 oncology & carcinogenesisNeoplasmExtracellular vesicleNeoplasm Recurrence LocalbusinessBiomarkersHumanEuropean Journal of Pharmaceutical Sciences
researchProduct

Dietary fatty acids and recurrence of colorectal adenomas in a European intervention trial.

2008

Epidemiological studies have provided inconsistent data about the role of dietary fatty acids in colorectal cancer, and few studies have addressed their role in colorectal adenoma. The aim of the study was to assess the risk of overall adenoma recurrence associated with dietary consumption of total fat, subtypes of fat, and specific fatty acids (oleic acid, linoleic acid, alpha-linolenic acid). The study sample was composed of 523 patients with confirmed adenomas at the index colonoscopy, 35 to 75 yr old, who completed the European fiber-calcium intervention trial and had an initial dietary assessment using a qualitative and quantitative food questionnaire. The overall 3-yr recurrence rate …

AdenomaAdultMaleCancer Researchmedicine.medical_specialtyAdenomaColorectal cancerLinoleic acidMedicine (miscellaneous)Colorectal adenomaGastroenterologyLinoleic Acidchemistry.chemical_compoundRisk FactorsInternal medicineSurveys and QuestionnairesEpidemiologymedicineOdds RatioHumansAgedchemistry.chemical_classificationNutrition and Dieteticsbusiness.industryFatty AcidsOdds ratioMiddle Agedmedicine.diseaseDietary FatsDietEuropeOleic acidOncologychemistryFatty Acids UnsaturatedFemaleNeoplasm Recurrence LocalbusinessColorectal NeoplasmsPolyunsaturated fatty acidNutrition and cancer
researchProduct

Image-guided endonasal transsphenoidal microsurgical treatment of recurrent microadenomas of the pituitary gland.

2006

BACKGROUND Neuronavigation is a commonly used technology that provides continuous, three-dimensional information for the precise localization of and surgical trajectory to brain lesions. This study was performed to evaluate the role that navigation can play in assisting microsurgical transsphenoidal surgery for precise localization and removal of recurrent pituitary tumours while simultaneously preserving pituitary gland function. METHOD During a 6-month period -- July 2004 until December 2004 -- 9 patients with recurrent pituitary tumours (5 female and 4-male) were treated with navigation-guided transsphenoidal microsurgical resection. Surgery was performed via a paraseptal or endonasal tr…

AdenomaAdultMalePituitary glandmedicine.medical_specialtyMicrosurgeryNeuronavigationAdenomamedicine.medical_treatmentmedicineHumansPituitary NeoplasmsSella TurcicaNeuronavigationRetrospective StudiesTranssphenoidal surgerybusiness.industryGeneral MedicineMicrosurgeryMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureNeuroendoscopyTreatment OutcomeCavernous sinusSurgeryFemaleNeurology (clinical)Corticotropic cellNeoplasm Recurrence LocalbusinessMinimally invasive neurosurgery : MIN
researchProduct

Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial

2005

The relations between individual foods and nutrients to colorectal tumours are conflicting. Few studies have taken into account the interdependence between individual components of diet and their possible interactions. The aim of the study was to examine the associations between dietary patterns and the risk of colorectal adenoma recurrence in the European fibre-calcium intervention trial. Among the 640 patients with confirmed adenomas at the index colonoscopy, 592 had an initial dietary assessment using a diet history questionnaire. The present analysis was restricted to 277 men and 165 women without history of adenoma prior to the index colonoscopy and who completed the study. The main en…

AdenomaDietary FiberMaleCancer Researchmedicine.medical_specialtyMultivariate analysisAdenomaEpidemiologyColonoscopyColorectal adenomaDiet MediterraneanFood groupSex FactorsRisk FactorsInternal medicineOdds RatiomedicineHumansAgedmedicine.diagnostic_testbusiness.industryPublic Health Environmental and Occupational HealthColonoscopyOdds ratioMiddle Agedmedicine.diseaseConfidence intervalCalcium DietaryEuropeEndocrinologyOncologyFemaleNeoplasm Recurrence LocalColorectal NeoplasmsbusinessDemographyIndex ColonoscopyEuropean Journal of Cancer Prevention
researchProduct

Standardized long-term follow-up after endoscopic resection of large, nonpedunculated colorectal lesions: a prospective two-center study.

2014

Endoscopic removal of large, nonpedunculated colorectal lesions is challenging. Long-term outcome data based on standardized protocols, including detailed inspection of the resection site, are scarce. The aims of the present study were to evaluate the safety and efficacy of endoscopic resection (ER) of large, nonpedunculated lesions (LNLs;20 mm) and to assess the long-term recurrence rate afterward.A total of 243 consecutive patients (141 men, 102 women) with 252 adenomas (20 mm) was followed up using a standardized protocol after complete ER. After endoscopic treatment, the patients received standardized follow-up examinations after 3-6 months and 12 months. The postpolypectomy scar was re…

AdenomaMalemedicine.medical_specialtyTime FactorsLong term follow upColonic PolypsGastroenterologyRisk AssessmentCohort StudiesPostoperative ComplicationsInternal medicineGermanyBiopsymedicineHumansEndoscopic resectionNeoplasm InvasivenessProspective StudiesProspective cohort studySurvival rateAgedMonitoring PhysiologicNeoplasm StagingAged 80 and overHepatologymedicine.diagnostic_testbusiness.industryBiopsy NeedleGastroenterologyFollow up studiesColonoscopyMiddle AgedImmunohistochemistrySurvival RateNeoplasm stagingFemaleRadiologyNeoplasm Recurrence LocalbusinessColorectal NeoplasmsCohort studyFollow-Up StudiesThe American journal of gastroenterology
researchProduct

Clinical results of transanal endoscopic microsurgery

1988

Using the "transanal endoscopic microsurgery" technique, 140 patients were treated at the Department of Surgery in Cologne and Mainz. Of the patients with adenomas, 68.2% had typical symptoms preoperatively. The postoperative hospital attendance was 8.7 days, with an average resection size of 14.4 cm2. The postoperative complication rate was 5%, and there were no deaths related to the technique. In a prospective controlled trial, 2.2% of the patients with adenomas treated endoscopically in Mainz showed recidivation, requiring reoperation. The follow-up rate was 100%. In 30 cases, microscopic examination revealed carcinoma. Radical reoperation in 8 pT1 tumours showed neither remaining tumour…

AdenomaReoperationMicrosurgerymedicine.medical_specialtyAdenomamedicine.medical_treatmentRectummedicineCarcinomaHumansProspective StudiesLymph nodeClinical Trials as Topicmedicine.diagnostic_testRectal Neoplasmsbusiness.industryIntestinal PolypsPostoperative complicationColonoscopyMicrosurgerymedicine.diseaseEndoscopySurgerymedicine.anatomical_structureColonic NeoplasmsSurgeryNeoplasm Recurrence LocalbusinessAbdominal surgerySurgical Endoscopy
researchProduct

CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in he…

2016

Constitutive epimutations of tumor suppressor genes are increasingly considered as cancer predisposing factors equally to sequence mutations. In light of the emerging role of the microenvironment for cancer predisposition, initiation, and progression, we aimed to characterize the consequences of a BRCA1 epimutation in cells of mesenchymal origin. We performed a comprehensive molecular and cellular comparison of primary dermal fibroblasts taken from a monozygous twin pair discordant for recurrent cancers and BRCA1 epimutation, whose exceptional clinical case we previously reported in this journal. Comparative transcriptome analysis identified differential expression of extracellular matrix-r…

Adult0301 basic medicineCancer ResearchTwinsHaploinsufficiencyKetone BodiesExtracellular matrixTranscriptome03 medical and health sciencesCell Line TumormedicineHumansGenes Tumor SuppressorMolecular BiologyPDPNCells CulturedOligonucleotide Array Sequence AnalysisSkinExtracellular Matrix ProteinsbiologyBRCA1 ProteinCell growthGenes HomeoboxCancerDNA MethylationFibroblastsmedicine.diseaseGene Expression Regulation Neoplastic030104 developmental biologyCulture Media ConditionedMutationDNA methylationImmunologyCancer researchbiology.proteinCytokinesCancer-Associated FibroblastsFemaleNeoplasm Recurrence LocalACTA2TranscriptomeResearch PaperEpigenetics
researchProduct

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer

2019

There is no sufficient evidence to establish a standard of care for patients with brain metastases (BM) from HER2Data of 154 patients were retrospectively collected at 14 Italian institutions through a specifically designed database.Median overall survival (OS) was 24.5 months. Patients receiving surgery/stereotactic radiosurgery experienced longer OS compared to those receiving whole-brain radiotherapy or no treatment (33.5 vs. 11.4 months; hazard ratio = 0.34; 95% confidence interval, 0.22-0.52; P .001). Interestingly, whole-brain radiotherapy did not improve OS compared to no treatment (11.4 vs. 9.8 months; hazard ratio = 0.99; 95% confidence interval, 0.62-1.62; P = .99). HER2-targeted …

Adult0301 basic medicineCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSocio-culturaleBreast NeoplasmsLapatinibTreatment experiencedRadiosurgerySRS03 medical and health sciences0302 clinical medicineBreast cancerTrastuzumabInternal medicineHER2 Positive Breast CancerBiomarkers TumormedicineHumansAgedRetrospective Studiesbusiness.industryLapatinibTrastuzumabMiddle AgedWBRTPrognosismedicine.diseaseCombined Modality TherapyConfidence intervalSurvival RateRadiation therapyLapatinib SRS Surgery Trastuzumab WBRT030104 developmental biologyReceptors EstrogenOncology030220 oncology & carcinogenesisLapatinib; SRS; Surgery; Trastuzumab; WBRTSurgeryFemaleNeoplasm Recurrence LocalbusinessFollow-Up Studiesmedicine.drugClinical Breast Cancer
researchProduct

Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women…

2016

PURPOSE: The 21-gene Recurrence Score assay (Oncotype DX) provides prognostic/predictive information in oestrogen receptor positive (ER+) early breast cancer, but access/reimbursement has been limited in most European countries in the absence of prospective outcome data. Recently, two large prospective studies and a real-life 5-year outcome study have been reported. We performed a pooled analysis of prospective European impact studies to generate robust data on impact of use in different clinical subgroups. METHODS: The analysis included four studies (French, German, Spanish, and British) in ER+ human epidermal growth factor receptor 2-negative breast cancer patients (n = 527). Node-positiv…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-2medicine.medical_treatmentClinical Decision-MakingBreast NeoplasmsMama -- Càncer -- TractamentRisk AssessmentSeverity of Illness Index03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerInternal medicineQuimioteràpiaHumansMedicineProspective StudiesOestrogen receptorPrecision MedicineStage (cooking)Prospective cohort studyReimbursementAgedAged 80 and overGynecologyChemotherapyIndividualised medicinemedicine.diagnostic_testbusiness.industryGene Expression ProfilingMiddle Agedmedicine.diseaseTumor BurdenAdjuvant chemotherapyEurope030104 developmental biologyReceptors EstrogenOncology030220 oncology & carcinogenesisHormonal therapyFemaleNeoplasm Recurrence LocalbusinessOncotype DXClinical decision makingEuropean Journal of Cancer
researchProduct